Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -44.23M
March 31, 2026 -49.88M
December 31, 2025 -46.24M
September 30, 2025 -46.07M
June 30, 2025 -54.54M
March 31, 2025 -50.55M
December 31, 2024 -49.69M
September 30, 2024 -50.80M
June 30, 2024 -53.09M
March 31, 2024 -58.13M
Date Value
December 31, 2023 -66.37M
September 30, 2023 -73.57M
June 30, 2023 -71.02M
March 31, 2023 -70.27M
December 31, 2022 -71.04M
September 30, 2022 -65.52M
June 30, 2022 -60.86M
March 31, 2022 -57.79M
December 31, 2021 -53.27M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Champions Oncology, Inc. -6.137M
Medpace Holdings, Inc. 706.69M
Avantor, Inc. 454.70M
Personalis, Inc. -100.98M
Adaptive Biotechnologies Corp. -24.03M